These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

25 related articles for article (PubMed ID: 37315250)

  • 1. [Results of a cohort single-center randomized study of the modulating effect of the drug Mexidol in the rehabilitation of patients who suffered acute cerebral insufficiency].
    Belkin AA; Belkin VA; Vasilchenko IE; Pinchuk EA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2024; 124(4):108-117. PubMed ID: 38676685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The use of Mexidol in patients with mild (moderate) cognitive impairment: results of a meta-analysis].
    Zakharov VV; Vakhnina NV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2024; 124(1):82-88. PubMed ID: 38261288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of patients with ishemic stroke in the vertebral-basilar system in acute period: experience of using the neuroprotective drug Mexidol].
    Goncharova ZA; Chernikova IV; Nazarova VA; Tolmacheva VV; Ovsepian KG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2024; 124(2):78-84. PubMed ID: 38465813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Features of pharmacotherapy of vascular cognitive impairment in the elderly].
    Bogolepova AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(9):15-20. PubMed ID: 37796062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacotherapy approaches to vascular mild cognitive impairment in patients of different age groups].
    Zakharov VV; Fedin AI; Mhitaryan EA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(10):26-32. PubMed ID: 37966436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seven-and-a-half syndrome.
    Xu Z; Zhao Y; Yan C; Ji K
    Pract Neurol; 2024 May; 24(3):250-251. PubMed ID: 38326019
    [No Abstract]   [Full Text] [Related]  

  • 7. [Efficacy and safety of ethylmethylhydroxypyridine succinate in patients with chronic cerebral ischemia].
    Zhuravleva MV; Prokofiev AB; Serebrova SY; Vasyukova NS; Demchenkova EY; Arkhipov VV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(6):119-124. PubMed ID: 32678558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combined administration of mexidol with known medicines].
    Voronina TA; Ivanova EA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(4):115-124. PubMed ID: 31156232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy of Mexidol in the correction of postcovid syndrome in patients with chronic cerebrovascular diseases].
    Kuznetsova EB; Salina EA; Kuznetsov NS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(5):117-122. PubMed ID: 37315250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neurometabolic therapy of mild cognitive impairment in patients with chronic cerebral ischemia].
    Antipenko EA; Shulyndin AV; Belyakov KM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2024; 124(3):42-51. PubMed ID: 38529862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The efficacy and safety study of Mexidol and Mexidol FORTE 250 in patients with chronic cerebral ischemia].
    Shchepankevich LA; Nikolaev YA; Taneeva EV; Pervuninskaya MA; Shchepankevich MS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(10):32-37. PubMed ID: 34874652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results of an international multicenter, randomized, double-blind, placebo-controlled study assessing the efficacy and safety of sequential therapy with Mexidol and Mexidol FORTE 250 in patients with chronic brain ischemia (MEMO)].
    Fedin AI; Zakharov VV; Tanashyan MM; Chukanova EI; Madzhidova EN; Shchepankevich LA; Ostroumova OD
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(11):7-16. PubMed ID: 34932280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Possibilities of improving the effectiveness of therapy in patients with chronic cerebral ischemia against the background of COVID-19].
    Kovalchuk VV; Ershova II; Molodovskaya NV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(3. Vyp. 2):60-66. PubMed ID: 33908234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Improving the effectiveness of pharmacotherapy in comorbid patients with chronic cerebral ischemia on an outpatient basis].
    Vizilo TL; Arefieva EG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(3):51-55. PubMed ID: 36946397
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.